System1Bio: Curing Brain Disease Using Humanity's Best Science

July 17, 2020

System1 combines next-generation patient-derived organoid models, scaled biology and machine learning to discover new treatments for brain disorders.  The company uses a vertically-integrated cloud-based drug discovery plaftorm called ORCA to target diseases through drug screening and analysis of multi-modal data including microscopy, functional neural dynamics,  immunoflourescent imaging and transcriptomics. 

Presented by Doug Flanzer, CTO, System1Bio

Previous Video
AWS: Leveraging Amazon AppFlow to transfer data between SaaS applications and AWS services
AWS: Leveraging Amazon AppFlow to transfer data between SaaS applications and AWS services

Presented by Venkatesh Krishnan, Product Lead for Amazon AppFlow, AWS

Next Video
AiCure: Building AI to Understand Patient Behavior
AiCure: Building AI to Understand Patient Behavior

Presented by Lei Guan, CTO, AiCure